Kidney Cancer and Adrenals
December 2011
A Stage-for-Stage and Grade-for-Grade Analysis of Cancer-Specific Mortality Rates in Renal Cell Carcinoma According to Age: A Competing-Risks Regression Analysis
Sun, M, Abdollah, F, Bianchi, M.
Competing-Risks Analysis for Renal Cell Carcinoma: How Do We Accurately Communicate the Risks and Benefits of Treatment to Patients?
Kim, SP, Thompson, RH.
Reply from Authors re: Simon P. Kim, R. Houston Thompson. Competing-Risks Analysis for Renal Cell Carcinoma: How Do We Accurately Communicate the Risks and Benefits of Treatment to Patients? Eur Urol 2011;60:1160–2
Sun, M, Abdollah, F, Bianchi, M.
Sequence Therapy in Patients with Metastatic Renal Cell Carcinoma: Comparison of Common Targeted Treatment Options Following Failure of Receptor Tyrosine Kinase Inhibitors
Busch, J, Seidel, C, Kempkensteffen, C.
Entropy Increases in Kidney Cancer Treatment, but a Bit of Simplicity May Emerge From Chaos
Porta,C.
November 2011
Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma
Chapin, B, Delacroix, S, Culp, S.
Safety Issues and Rationale for Neoadjuvant Approaches in Renal Cell Carcinoma
Bessede, T, Pignot, G, Patard, J.
Metastatic Potential in Renal Cell Carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register Data
Guðmundsson, B, Hellborg, H, Lundstam, S.
Metastatic Potential of the Small Renal Mass: Why Can’t We Agree?
Umbreit, E, Thompson, H.
Reply from Authors re: Eric C. Umbreit, R. Houston Thompson. Metastatic Potential of the Small Renal Mass: Why Can’t We Agree? Eur Urol 2011;60:983–5
Ljungberg, B, Guðmundsson, E, Hellborg, H.
Familial Renal Cell Carcinoma from the Swedish Family-Cancer Database
Liu,H, Sundquist, J, Hemminki, K.
Familial Clustering of Sporadic Kidney Cancer: Insufficient Evidence to Recommend Routine Screening in Unaffected Kin
Smaldone, M, Giri, V, Uzzo, R.
October 2011
Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy
Simhan, J, Smaldone, M, Tsai, K.
Anatomic Classification Systems of Renal Tumors: New, Useful Tools in Renal Surgical Oncology
Volpe, A, Terrone, C.
September 2011
Laparoscopic Cryoablation Versus Partial Nephrectomy for the Treatment of Small Renal Masses: Systematic Review and Cumulative Analysis of Observational Studies
Klatte, T, Grubmüller, B, Waldert, M.
Is Laparoscopic Cryoablation a Less Invasive and Effective Procedure to Treat Small Renal Masses?
Novara, G, Ficarra, V.
Reply from Authors re: Giacomo Novara, Vincenzo Ficarra. Is Laparoscopic Cryoablation a Less Invasive and Effective Procedure to Treat Small Renal Masses? Eur Urol 2011;60:444–
Remzi, M, Klatte, T.
The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
Powles, T, Blank, C, Chowdhury, S.
Sunitinib Prior to Planned Cytoreductive Nephrectomy: Is This the New Litmus Test for Metastatic Renal Cell Carcinoma?
Kim, S, Thompson, H.
Routine Adrenalectomy in Patients with Locally Advanced Renal Cell Cancer Does Not Offer Oncologic Benefit and Places a Significant Portion of Patients at Risk for an Asynchronous Metastasis in a Solitary Adrenal Gland
Weight, C.J, Kim, S, Lohse, C.
Reply from Authors re: Christian G. Stief. If a Partial Nephrectomy Could Be Done Safely for a Renal Tumor, Would Radical Nephrectomy Be Considered Malpractice? Eur Urol 2011;60:465–6
Weight, C.J, Leibovich, B.
2011- August
http://www.sciencedirect.com/science/article/pii/S0302283811005185?_rdoc=32&_fmt=high&_origin=browse&_srch=doc-info%28%23toc%237228%232011%23999399997%233353794%23FLA%23display%23Volume%29&_docanchor=&_ct=49&_refLink=Y&_zone=rslt_list_item&md5=ba13d961abc99321e96242a68e7634d3Best Article!
Impact of Venous Tumour Thrombus Consistency (Solid vs Friable) on Cancer-specific Survival in Patients with Renal Cell Carcinoma
Bertini, R, Roscigno, M, Freschi, M.
Platinum Priority!
Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score
Kutikov, A, Smaldone, M, Egleston, B.
Platinum Priority!
The RENAL Nephrometry Nomogram: Statistically Significant, But Is It Clinically Relevant?
Chapin, B, Wood, CG
Platinum Priority! Reply from Authors re: Brian F. Chapin, Christopher G. Wood. The RENAL Nephrometry Nomogram: Statistically Significant, But Is It Clinically Relevant? Eur Urol 2011;60:249–51
Kutikov, A, Uzzo, R.
2011-July
Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer
Jewett, M, Mattar, K, Basiuk, J.
Small Renal Mass and Low-Risk Prostate Cancer: Any More for Active Surveillance?
Yates, DR, Rouprêt, M.
Prediction of Progression-Free Survival Rates After Bevacizumab Plus Interferon Versus Interferon Alone in Patients with Metastatic Renal Cell Carcinoma: Comparison of a Nomogram to the Motzer Criteria
Karakiewicz, P, Sun, M, Bellmunt, J.
A Prognostic Model for Patients With Metastatic Renal Cell Cancer: What's New?
Di Lorenzo, G.
2011- June
Platinum Priority! The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus
Cost, N,G, Delacroix Jr, S, Sleeper, J, P.
With the following accompanying Editorial
Targeted Caval Cytoreduction: Solid Foundations or Shifting Sands?
Bex, A, Clarke, N.
Reply from Authors re: Axel Bex, Noel Clarke. Targeted Caval Cytoreduction: Solid Foundations or Shifting Sands?
Cost, N,G, Margulis, V.
Platinum Priority! Preoperative Nutritional Status Is an Important Predictor of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma
Morgan, T, M, Tang, D, Stratton, K, L.
With the following accompanying Editorial
Does Preoperative Nutritional Status Affect Survival in Renal Cell Carcinoma? The Debate Continues
Capitanio, U, Montorsi, F.
Platinum Priority! Short-Term Functional and Oncologic Outcomes of Nephron-Sparing Surgery for Renal Tumours ≥7 cm
Becker, F, Roos, F, C, Janssen, M.
With the following accompanying Editorial
Expanding the Indications of Partial Nephrectomy
Rogers, C, G.
2011- May
Best Article! Laparoscopic Partial Nephrectomy With Segmental Renal Artery Clamping: Technique and Clinical Outcomes
Shao, P, Qin, C.
Best Article!Comparison of Four Early Posttherapy Imaging Changes (EPTIC; RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor–Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
Krajewski, K, Guo, M,
Best Article!Growth Kinetics of Renal Masses: Analysis of a Prospective Cohort of Patients Undergoing Active Surveillance
Mason, R, Abdolell, M, Trottier, G.
Platinum Priority!Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature
Youssef, Y, White, N, Grigull, J.
With the following accompanying Editorial
Molecular Profiling of Renal Cancer: The Journey to Clinical Application
Ribal, M.
Platinum Priority!Anoikis Disruption of Focal Adhesion-Akt Signaling Impairs Renal Cell Carcinoma
Sakamoto, S, Schwarze, S, Kyprianou, N.
With the following accompanying Editorial
Lord of the Rings: A Promising Novel Treatment for Renal Cell Carcinoma?
Johansson, M.
2011- April
Best Article! Development and Characterization of Clinically Relevant Tumor Models From Patients With Renal Cell Carcinoma
Karam, J, Zhang, X, Tamboli, P.
2011-March
Platinum Priority! Multi-Institutional Analysis of Robotic Partial Nephrectomy for Hilar Versus Nonhilar Lesions in 446 Consecutive Cases
Dulabon, L, Kaouk, J H, Haber, G P.
With the following accompanying Editorial
Is Robot-Assisted Partial Nephrectomy Already Mature for Challenging Cases?
Paparel, P, Bessede, T, Patard, J.
Platinum Priority! Adverse Renal Outcomes in Subjects Undergoing Nephrectomy for Renal Tumors: A Population-Based Analysis
Klarenbach, S, Moore, R, Chapman, D.
With the following accompanying Editorial
Deleterious Renal Functional Outcomes After Radical Nephrectomy
Russo, P.
2011- February
Best Article!Is There a Need to Further Subclassify pT2 Renal Cell Cancers as Implemented by the Revised 7th TNM Version?
Waalkes,, S, Becker, F, Schrader,A, J.
2011 - January
Platinum Priority!Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma
Abel, E, Culp, S, Tannir, N.
With the following accompanying Editorial
Is Tumor Response Important for Renal Carcinoma?
Inman, B, George, D.
Platinum Priority! Lymph Node Dissection at the Time of Radical Nephrectomy for High-Risk Clear Cell Renal Cell Carcinoma: Indications and Recommendations for Surgical Templates
Crispen,P, Breau, R, Allmer, C.
With the following accompanying Editorial
Lymph node dissection is not obsolete in clinically node-negative Renal Cell Carcinoma patients
Van Poppel, H.
Best Article! Prognostic Impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous Extension
Martínez-Salamanca, J, Huang, W.
Best Article! “Zero Ischemia” Partial Nephrectomy: Novel Laparoscopic and Robotic Technique
Gill, I, Eisenberg, M.
Best Article! Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis
Sun, M, Thuret, R, Abdollah, F.
2010 - December
Integrating Surgery with Targeted Therapies for Renal Cell Carcinoma: Current Evidence and Ongoing Trials
Bex, A, Jonasch, E, Kirkali, Z
With the following accompanying Editorial
Integrating Surgery with Targeted Therapies for Renal Cell Carcinoma: Maximizing Benefits, Minimizing Risk
Clarke, NW
2010 -November
Prognostic and Therapeutic Impact of the Histopathologic Definition of Parenchymal Epithelial Renal Tumors
Ficarra, V, Brunelli, M, Cheng, L.
Peering Through the Microscope Lens Into the Future
Tollefson, MK, Thompson, RH.
2010-October
Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed?
Novara, G, Ficarra, V, Antonelli, A.
Recovery of Renal Function After Open and Laparoscopic Partial Nephrectomy
Adamy, A, Favaretto, RL, Nogueira, L.
Raman Spectroscopy: A Novel Experimental Approach to Evaluating Renal Tumours
Bensalah, K, Fleureau, J, Rolland, D.
2010 - September
Comparison of Warm Ischemia Versus No Ischemia During Partial Nephrectomy on a Solitary Kidney
Thompson, R.H. Lane, B.R. Lohse, C.M.
With the following accompanying Editorial
Warm Ischaemia: The Ultimate Enemy for Partial Nephrectomy?
Pignot, G. Bouliere, F.Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy
Thompson, R.H. Lane, B.R. Lohse, C.M.
Nephron-Sparing Surgery: Some Considerations Regarding an Underused Standard of Care
Alcaraz, A.
2010 - February
A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma
Karakiewicz PI, Suardi N, Capitanio U et al
with the following accompanying Editorial and rebuttal from the Authors
Decision Making in the Management of Renal Cell Carcinoma: Can Nomograms Assist?
Bolenz C, Lotan Y
Rebuttal from Authors re: Christian Bolenz, Yair Lotan. Decision Making in the Management of Renal Cell Carcinoma: Can Nomograms Assist? Eur Urol 2009;55:296–8
Capitanio U, Karakiewicz PI
2010 - January
Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881
Blom JHM, van Poppel H, Maréchal JM et al
with the following accompanying Editorial
Lymphadenectomy Combined with Radical Nephrectomy: To Do or Not to Do?
Studer UE, Birkhäuser FD
